ELISA Kit for Amiloride Binding Protein 1 (ABP1) Ver mas grande

ELISA Kit for Amiloride Binding Protein 1 (ABP1)

CC-SEA656Ra

Producto nuevo

48T, 96T, 96T×5, 96T×10, 96T×100

Más detalles

Por favor regístrese para ver el precio

Comprando este producto generará 6 Biopuntos. Su cesta contiene un total 6 Biopuntos puede ser convertido en un Biobonos Descuento 24.00EUR.


Añadir a Mis Favoritos

Hoja técnica

Size 96T
Storage Conditions -20°C
Shipping Conditions Entre 4°C y 8°C
Applications Enzyme-linked immunosorbent assay for Antigen Detection.
Detection Range 0.625-40ng/mL
Sensitivity The minimum detectable dose of this kit is typically less than 0.223ng/mL
Research Area Enzyme & Kinase
Organism species Rattus norvegicus (Rat)
Alternative Names AOC1
Item Name Amiloride Binding Protein 1
Assay Length 3h
Method Double-antibody Sandwich
Sample Type Serum, plasma, tissue homogenates, cell lysates and other biological fluids
Formato 48T, <i>96T</i>, 96T×5, 96T×10, 96T×100
Test Principle The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Amiloride Binding Protein 1 (ABP1). Standards or samples are then added to the appropriate mi
Assay procedure summary 1. Prepare all reagents, samples and standards
UniProt ID P36633

Más información

Click here for manual in PDF

Click here for OD Image


CITATIONS
A multi-component herbal preparation, STW 5, shows anti-apoptotic effects in radiation induced intestinal mucositis in rats;Elevation of HO-1 Expression Mitigates Intestinal Ischemia-Reperfusion Injury and Restores Tight Junction Function in a Rat Liver Transplantation Model;Early prediction of intestinal mucosal barrier function impairment by elevated serum procalcitonin in rats with severe acute pancreatitis.;Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats;Protective effect of aplysin on liver tissue and the gut microbiota in alcohol-fed rats;Protective Effect of Aplysin Supplementation on Intestinal Permeability and Microbiota in Rats Treated with Ethanol and Iron;The effect of fucoidan on intestinal flora and intestinal barrier function in rats with breast cancer;Effects of fecal microbiota transplantation and joint application of probiotics on rats with alcoholic liver disease;Liraglutide Attenuates Nonalcoholic Fatty Liver Disease by Modulating Gut Microbiota in Rats Administered a High-Fat Diet;HMGB1‐associated necroptosis and Kupffer cells M1 polarization underlies remote liver injury induced by intestinal ischemia/reperfusion in rats;Effects of fucoidan on tumor prevention and gut flora;Design and development of novel fasudil derivatives as potent anti‐breast cancer agent that improves intestinal flora and intestinal barrier function in rats;Bovine lactoferricin ameliorates intestinal inflammation and mucosal barrier lesions in colitis through NF-κB/NLRP3 signaling pathways;Transplanted hair follicle mesenchymal stem cells alleviated small intestinal ischaemia–reperfusion injury via intrinsic and paracrine mechanisms in a rat model;